158 related articles for article (PubMed ID: 28163121)
1. (-)-Epigallocatechin gallate synergistically potentiates prostaglandin E
Kuroyanagi G; Tokuda H; Yamamoto N; Kainuma S; Fujita K; Ohguchi R; Kawabata T; Sakai G; Matsushima-Nishiwaki R; Harada A; Kozawa O; Otsuka T
Prostaglandins Other Lipid Mediat; 2017 Jan; 128-129():27-33. PubMed ID: 28163121
[TBL] [Abstract][Full Text] [Related]
2. (--)-epigallocatechin gallate enhances prostaglandin F2alpha-induced VEGF synthesis via upregulating SAPK/JNK activation in osteoblasts.
Tokuda H; Takai S; Matsushima-Nishiwaki R; Akamatsu S; Hanai Y; Hosoi T; Harada A; Ohta T; Kozawa O
J Cell Biochem; 2007 Apr; 100(5):1146-53. PubMed ID: 17031857
[TBL] [Abstract][Full Text] [Related]
3. Amplification by (‑)‑epigallocatechin gallate of prostaglandin F2α‑stimulated synthesis of osteoprotegerin in osteoblasts.
Sakai G; Otsuka T; Fujita K; Kainuma S; Kuroyanagi G; Kawabata T; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2017 Nov; 16(5):6376-6381. PubMed ID: 28849144
[TBL] [Abstract][Full Text] [Related]
4. Resveratrol reduces prostaglandin E1-stimulated osteoprotegerin synthesis in osteoblasts: suppression of stress-activated protein kinase/c-Jun N-terminal kinase.
Yamamoto N; Otsuka T; Kuroyanagi G; Kondo A; Kainuma S; Nakakami A; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Prostaglandins Other Lipid Mediat; 2015; 116-117():57-63. PubMed ID: 25677506
[TBL] [Abstract][Full Text] [Related]
5. Regulation by resveratrol of prostaglandin E2-stimulated osteoprotegerin synthesis in osteoblasts.
Yamamoto N; Tokuda H; Kuroyanagi G; Mizutani J; Matsushima-Nishiwaki R; Kondo A; Kozawa O; Otsuka T
Int J Mol Med; 2014 Nov; 34(5):1439-45. PubMed ID: 25234201
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epigallocatechin gallate reduces platelet-derived growth factor-BB-stimulated interleukin-6 synthesis in osteoblasts: suppression of SAPK/JNK.
Takai S; Matsushima-Nishiwaki R; Adachi S; Natsume H; Minamitani C; Mizutani J; Otsuka T; Tokuda H; Kozawa O
Mediators Inflamm; 2008; 2008():291808. PubMed ID: 19148296
[TBL] [Abstract][Full Text] [Related]
7. Acetaminophen reduces osteoprotegerin synthesis stimulated by PGE
Kim W; Tokuda H; Tanabe K; Yamaguchi S; Hioki T; Tachi J; Matsushima-Nishiwaki R; Kozawa O; Iida H
Biomed Res; 2021; 42(2):77-84. PubMed ID: 33840687
[TBL] [Abstract][Full Text] [Related]
8. Regulation by AMP-activated protein kinase of PGE2-induced osteoprotegerin synthesis in osteoblasts.
Kainuma S; Otsuka T; Kuroyanagi G; Yamamoto N; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Mol Med Rep; 2016 Apr; 13(4):3363-9. PubMed ID: 26935864
[TBL] [Abstract][Full Text] [Related]
9. (-)-Epigallocatechin gallate reduces transforming growth factor beta-stimulated HSP27 induction through the suppression of stress-activated protein kinase/c-Jun N-terminal kinase in osteoblasts.
Hayashi K; Takai S; Matsushima-Nishiwaki R; Hanai Y; Kato K; Tokuda H; Kozawa O
Life Sci; 2008 May; 82(19-20):1012-7. PubMed ID: 18407296
[TBL] [Abstract][Full Text] [Related]
10. (-)-Epigallocatechin gallate amplifies interleukin-1-stimulated interleukin-6 synthesis in osteoblast-like MC3T3-E1 cells.
Kuroyanagi G; Otsuka T; Kondo A; Matsushima-Nishiwaki R; Mizutani J; Kozawa O; Tokuda H
Biochimie; 2013 Oct; 95(10):1933-8. PubMed ID: 23851196
[TBL] [Abstract][Full Text] [Related]
11. (-)-Epigallocatechin gallate but not chlorogenic acid suppresses EGF-stimulated migration of osteoblasts via attenuation of p38 MAPK activity.
Kawabata T; Otsuka T; Fujita K; Sakai G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Int J Mol Med; 2018 Dec; 42(6):3149-3156. PubMed ID: 30272256
[TBL] [Abstract][Full Text] [Related]
12. (-)-Epigallocatechin gallate suppresses endothelin-1-induced interleukin-6 synthesis in osteoblasts: inhibition of p44/p42 MAP kinase activation.
Tokuda H; Takai S; Hanai Y; Matsushima-Nishiwaki R; Hosoi T; Harada A; Ohta T; Kozawa O
FEBS Lett; 2007 Apr; 581(7):1311-6. PubMed ID: 17350626
[TBL] [Abstract][Full Text] [Related]
13. (-)-epigallocatechin gallate inhibits prostaglandin D2-stimulated HSP27 induction via suppression of the p44/p42 MAP kinase pathway in osteoblasts.
Yamauchi J; Takai S; Matsushima-Nishiwaki R; Hanai Y; Doi T; Kato H; Ogura S; Kato K; Tokuda H; Kozawa O
Prostaglandins Leukot Essent Fatty Acids; 2007; 77(3-4):173-9. PubMed ID: 17949962
[TBL] [Abstract][Full Text] [Related]
14. Amplification by tramadol of PGD
Hioki T; Tokuda H; Tanabe K; Kim W; Tachi J; Yamaguchi S; Matsushima-Nishiwaki R; Kozawa O; Iida H
Prostaglandins Leukot Essent Fatty Acids; 2021 Sep; 172():102323. PubMed ID: 34392133
[TBL] [Abstract][Full Text] [Related]
15. Suppression by resveratrol of prostaglandin D2-stimulated osteoprotegerin synthesis in osteoblasts.
Kuroyanagi G; Mizutani J; Kondo A; Yamamoto N; Matsushima-Nishiwaki R; Otsuka T; Kozawa O; Tokuda H
Prostaglandins Leukot Essent Fatty Acids; 2014 Sep; 91(3):73-80. PubMed ID: 24813642
[TBL] [Abstract][Full Text] [Related]
16. Involvement of SAPK/JNK in prostaglandin E(1)-induced VEGF synthesis in osteoblast-like cells.
Kanno Y; Tokuda H; Nakajima K; Ishisaki A; Shibata T; Numata O; Kozawa O
Mol Cell Endocrinol; 2004 May; 220(1-2):89-95. PubMed ID: 15196703
[TBL] [Abstract][Full Text] [Related]
17. (-)-Epigallocatechin gallate inhibits thyroid hormone-stimulated osteocalcin synthesis in osteoblasts.
Kato K; Otsuka T; Adachi S; Matsushima-Nishiwaki R; Natsume H; Kozawa O; Tokuda H
Mol Med Rep; 2011; 4(2):297-300. PubMed ID: 21468567
[TBL] [Abstract][Full Text] [Related]
18. PGD2 stimulates osteoprotegerin synthesis via AMP-activated protein kinase in osteoblasts: Regulation of ERK and SAPK/JNK.
Kainuma S; Tokuda H; Kuroyanagi G; Yamamoto N; Ohguchi R; Fujita K; Matsushima-Nishiwaki R; Kozawa O; Otsuka T
Prostaglandins Leukot Essent Fatty Acids; 2015 Oct; 101():23-9. PubMed ID: 26365271
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol suppresses prostaglandin F(2α)-induced osteoprotegerin synthesis in osteoblasts: inhibition of the MAP kinase signaling.
Kuroyanagi G; Tokuda H; Matsushima-Nishiwaki R; Kondo A; Mizutani J; Kozawa O; Otsuka T
Arch Biochem Biophys; 2014 Jan; 542():39-45. PubMed ID: 24333336
[TBL] [Abstract][Full Text] [Related]
20. (-)-Epigallocatechin gallate but not chlorogenic acid upregulates osteoprotegerin synthesis through regulation of bone morphogenetic protein-4 in osteoblasts.
Fujita K; Otsuka T; Yamamoto N; Kainuma S; Ohguchi R; Kawabata T; Sakai G; Kuroyanagi G; Matsushima-Nishiwaki R; Kozawa O; Tokuda H
Exp Ther Med; 2017 Jul; 14(1):417-423. PubMed ID: 28672948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
